BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Atreca Slashes One-Fourth Of Workforce in Reorganization Strategy

  Atreca is reducing its staff count by over 25%, covering current employees and open roles, and revising its operating plan to reflect these cost-cutting measures.

  June 2, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  BMS-Backed Transition Bio Scores $50M to Mine Biomolecular Condensates for Therapeutic Use

  Transition Bio has a four-component platform called Condensomics which provides a technological method to understand the properties of condensates.

  June 2, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  AstraZeneca CEO Knighted by Queen for COVID-19 Leadership

  AstraZeneca CEO Pascal Soriot has been knighted in the Queen’s Birthday Honours for his contribution to life sciences and leadership during the COVID-19 pandemic.

  June 2, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Business

  Seattle’s Sana Biotech Shifts Manufacturing to Bothell, Washington, Adds Key Leaders

  Seattle-based Sana Biotechnology is moving on from its current Fremont, California manufacturing facility, inking a lease deal to develop a manufacturing plant in Bothell, Washington.

  June 2, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Money on the Move: Sapience Scores $41m Backed by BMS, NexPoint

  Most money moves happened in Europe this week, including a government-backed award for Parkinson’s disease research and seed funding for an RNA platform.

  June 2, 2022

   · 

  4 min read

   · 

  Hannah Chudleigh
• 

  Business

  Upstream Bio Dives into Severe Asthma Space with $200M in Series A Financing

  Upstream Bio is focusing its efforts on an experimental treatment for severe asthma licensed from Astellas Pharma.

  June 2, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Business

  Roche, Repare Ink $1.2B Deal for Development of Cancer Therapy

  Repare Therapeutics announced a global cancer collaboration valued at up to $1.2 billion with Swiss pharma giant Roche for the development and commercialization of camonsertib.

  June 2, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Another Journal Retracts Paper Co-Authored by Cassava Sciences Key Collaborator

  Cassava Sciences is reeling after another journal retracted an article co-authored by a key collaborator on its experimental Alzheimer’s disease therapeutic, simufilam.

  June 2, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Novel TCR Therapy Shows Tentative Promise Against Pancreatic Cancer

  Researchers at the Earle A. Chiles Research Center have successfully shrunk a woman’s pancreatic cancer tumors using a novel immunotherapy.

  June 2, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano M.S.
• 

  Drug Development

  Kids Under 5 Could Soon Be Eligible for Pfizer-BioNTech’s COVID-19 Vaccine

  Children under the age of five could be eligible to receive Pfizer-BioNTech’s vaccine against COVID-19 as soon as late June.

  June 2, 2022

   · 

  2 min read

   · 

  Hayley Shasteen